NCT05584995

Brief Summary

The aim of this study is to assess Uterine artery color doppler parameters after bilateral uterine artery ligation (BUAL) for Postpartum Hemorrhage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 18, 2022

Completed
Last Updated

February 9, 2023

Status Verified

February 1, 2023

Enrollment Period

2.1 years

First QC Date

October 11, 2022

Last Update Submit

February 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Color Doppler parameters

    Color Doppler parameters for measuring the UtA diameters as UtA pulsatility Index will be recorded

    After Bilateral Uterine Artery Ligation

Secondary Outcomes (3)

  • The uterine artery's descending branches

    After Bilateral Uterine Artery Ligation

  • The uterine artery's ascending branch

    After Bilateral Uterine Artery Ligation

  • Color Doppler parameters

    After Bilateral Uterine Artery Ligation

Study Arms (2)

Control group

EXPERIMENTAL

Women will undergo normal cesarean section without Postpartum Hemorrhage or Idiopathic pulmonary hemosiderosis (IPH)

Procedure: Control group

BUAL group

EXPERIMENTAL

Cases will undergo Bilateral Uterine Artery Ligationafter Postpartum Hemorrhage after cesarean section resistant to medical treatment and did not need a hysterectomy.

Procedure: BUAL group

Interventions

Control groupPROCEDURE

Women will undergo normal cesarean section without Postpartum Hemorrhage or Idiopathic pulmonary hemosiderosis (IPH)

Control group
BUAL groupPROCEDURE

Bilateral Uterine Artery Ligation Technique: All uterine surgeries will be conducted by externalizing the uterus as much as possible and holding it by the fundus. The BUAL will be done using absorbable suture no. 1 Vicryl (Vicryl 1, Ethicon, France, Neuvilly-sur-Seine, France) will be placed through an avascular space in the broad ligament and tied from the anterior to posterior aspects of the myometrium 2-3 cm medial to the descending portion of the uterine vessels. In all patients, the suture will be carried from the anterior to the posterior at 1 cm to the myometrium medial to the Uterine artery and will be knotted after passing it through the avascular region at 1 cm to the wide ligament section adjacent to the uterus in both sides. All patients will be examined for uterotonics during and after the surgery. The ovarian arteries will be assessed at the level of the ovarian hilum.

BUAL group

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Details70 women aged between 20 and 35 years old. Cases underwent Bilateral Uterine Artery Ligation after Postpartum Hemorrhageafter cesarean section, resistant to medical treatment, and did not need to hysterectomy. The Control group will undergo normal cesarean section without Postpartum Hemorrhage or Idiopathic pulmonary hemosiderosis (IPH)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • women aged between 20 and 35 years old.
  • Undergoing Bilateral Uterine Artery Ligation after Postpartum Hemorrhageafter cesarean section
  • resistant to medical treatment, and did not need to hysterectomy.

You may not qualify if:

  • Patients with male factor, tubal factor, and absence of lactation.
  • Diabetes mellitus, hypertension, morbid obesity, autoimmune disease, or vascular disease in the history, smoking.
  • Intrauterine growth restriction in previous pregnancies history, detection of a uterine anomaly or a medical condition, as well as administration of a hormonal treatment during the study.
  • Uncontrolled bleeding is needed for a hysterectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed M.E. Ossman

Tanta, El-Gharbia Governorate, Egypt

Location

MeSH Terms

Conditions

Postpartum Hemorrhage

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

October 11, 2022

First Posted

October 18, 2022

Study Start

August 1, 2020

Primary Completion

August 20, 2022

Study Completion

August 20, 2022

Last Updated

February 9, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

The data will be available under a reasonable request from the corresponding author.

Shared Documents
STUDY PROTOCOL
Time Frame
One year after the end of the study

Locations